Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development
Open Access
- 25 September 2012
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 361 (1-2), 1-11
- https://doi.org/10.1016/j.mce.2012.03.026
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Cryptochromes mediate rhythmic repression of the glucocorticoid receptorNature, 2011
- Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in miceJournal of Hepatology, 2011
- The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expressionJournal of Hepatology, 2010
- Biological effects of growth hormone on carbohydrate and lipid metabolismGrowth Hormone & IGF Research, 2010
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- Disruption of the growth hormone-Signal transducer and activator of transcription 5-Insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasisJournal of Hepatology, 2009
- Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid MetabolismOnline Journal of Public Health Informatics, 2009
- Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activationThe Journal of Experimental Medicine, 2009
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenes & Development, 2008